CHICAGO, Sept. 15, 2021 /PRNewswire/ -- The Foundation for Sarcoidosis Research (FSR), the leading international nonprofit organization dedicated to finding a cure for sarcoidosis and improving care for sarcoidosis patients, is excited to share that a new article focused on sarcoidosis has been published by the New England Journal of Medicine (NEJM), the most influential authority in the field of medicine This article, Challenges of Sarcoidosis and Its Management, was written by two of FSR's Scientific Board Advisory (SAB) members, Elliott Crouser, MD, Ohio State University (Chair of the FSR SAB) and Marjolein Drent, MD, PhD, St. Antonius Hospital.
Sarcoidosis is a rare inflammatory multi-system disease. As a rare disease, sarcoidosis is not well-understood and often overlooked. This article details the risk factors associated with the development of sarcoidosis, highlighting the increased risk for African American's and women. Additionally, this foundational article explores the different clinical and diagnostic features and understanding of the clinical presentation of the disease and provides guidance for more timely and accurate diagnosis. Finally, this review provides a deeper understanding of the clinical presentation, understanding of prognosis, and pathways to better disease management for those living with sarcoidosis.
"Delayed diagnosis and lack of understanding of sarcoidosis are significant barriers to care for those living with sarcoidosis," says Mary McGowan, CEO for the Foundation for Sarcoidosis Research. "This article will be instrumental in providing all health care providers a deeper understanding of how to best diagnosis and treat this disease resulting in better patient outcomes."
Challenges of Sarcoidosis and Its Management is the first sarcoidosis scientific article published in NEJM since 2007 and is now considered the new standard of sarcoidosis review. To read the full report, visit https://www.nejm.org/doi/full/10.1056/NEJMra2101555?rss=searchAndBrowse
To learn more about FSR's research in sarcoidosis, please visit www.stopsarcoidosis.org.
Sarcoidosis is a rare inflammatory disease characterized by the formation of granulomas—tiny clumps of inflammatory cells — in one or more organs of the body. Despite increasing advances in research, sarcoidosis remains difficult to diagnose with limited treatment options and no known cure.
About the Foundation for Sarcoidosis Research (FSR)
Established in 2000, The Foundation for Sarcoidosis Research (FSR) is the leading international nonprofit organization dedicated to finding a cure for sarcoidosis and improving care for sarcoidosis patients. Since inception, FSR has fostered over $5 million in sarcoidosis-specific research efforts and has worked diligently to provide resources to thousands. For more information and to join our community, visit www.stopsarcoidosis.org.
312-341-0500 ext 106
SOURCE Foundation for Sarcoidosis Research